ARCHIVES

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments.

March 12, 2004

CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval

June 11, 1982

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

Abstracts From AACR Annual Meeting

May 21, 1976

Study Explores Reasons Women Avoid Mammograms

February 25, 2011